Makers Laboratories

Makers Laboratories Interest Coverage

The Interest Coverage Ratio of Makers Laboratories (506919.BO) as of Oct 17, 2026 is 3.72. In the previous year, Interest Coverage Ratio was -1.13 — a change of -430.30% (higher).

Interest Coverage

3.72

YoY

-430.30%

Last updated:

Interest Coverage Ratio of Makers Laboratories is 2025 3.72 . Interest Coverage Ratio of Makers Laboratories was 2024 -1.13 . It decreases by -430.30% higher compared to the previous year.

The Makers Laboratories Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2018
8.15 INR
Jan 1, 2019
87.87 INR
Jan 1, 2020
1.34 INR
Jan 1, 2021
6.51 INR
Jan 1, 2022
90.92 INR
Jan 1, 2023
3.19 INR
Jan 1, 2024
-1.13 INR
Jan 1, 2025
3.72 INR
The Makers Laboratories Interest Coverage history
YEARInterest CoverageYoY
3.72-430.30%
-1.13-135.32%
3.19-96.49%
90.92+1,296.30%
6.51+384.80%
1.34-98.47%
87.87+977.82%
8.15-50.65%
16.52+54.79%
10.67+43.85%
7.42+108.78%
3.55—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Makers Laboratories Stock analysis

What does Makers Laboratories do? Makers Laboratories Ltd is a pharmaceutical company headquartered in Mumbai, India, operating within the Health Care sector. The company has a workforce of 121 employees and went public on July 13, 1993. It manufactures and markets pharmaceutical products, focusing on various therapeutic segments. The company's product portfolio includes formulation brands such as Duramol (Paracetamol), Artemak-AB, Loroquin (Chloroquine), Nimuwin (Nimuselide), Coffwin (anti-cough range), and Exylin (Amoxycillin range). Additionally, Makers Laboratories offers Inspira retail packs, covering categories like acid regulatory, anthelmintics, anti-allergic, anti-asthmatic, anti-biotics, anti-diabetics, anti-diarrheal, anti-emetics, anti-nauseants, anti-fungal, anti-hypertensives, and other health-related products. The Experia bulk packs division provides bulk pharmaceutical products including amoxycillin 250 mg capsules, betamethasone 0.5 mg tablets, cetirizine HCL 10 mg tablets, chloramphenicol capsules 250 mg, chloroquine phosphate 250 mg tablets, chlorpheniramine maleate 4 mg tablets, ciprofloxacin hydrochloride 250 mg tablets, and similar items. The company's website is https://www.makerslabs.com/. Makers Laboratories Ltd is listed on the Bombay Stock Exchange under the ticker 506919.BO and holds the ISIN INE987A01010. The company operates through the pharmaceuticals segment, emphasizing general health therapeutic areas. It does not disclose specific financial figures or additional details beyond its product lines and operational structure. Makers Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Makers Laboratories stock

Interest Coverage Ratio of Makers Laboratories is 3.72 in 2025.

Interest Coverage Ratio of Makers Laboratories changed from -1.13 to 3.72, representing a -430.30% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Makers Laboratories since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Makers Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Makers Laboratories

All Key Metrics — Makers Laboratories